IP Library › Assignment 027019/0059
Patent Assignment
Reel/Frame 027019/0059

Change of Name

Recorded: 2011-10-05 Pages: 4
Assignor
EURAND, INC.
Executed: 2011-07-12
Assignee
APTALIS PHARMATECH, INC.
845 CENTER DRIVE, VANDALIA, OHIO, 45377
Covered Properties (10)
Controlled Release Potassium Chloride Tablets
Patent: 7,632,521 →
Application: 10/619,924 →
Publication: US 2005/0013860
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Patent: 7,387,793 →
Application: 10/713,929 →
Publication: US 2005/0106247
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Patent: 7,820,203 →
Application: 12/026,882 →
Publication: US 2008/0124398
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Patent: 7,544,372 →
Application: 12/026,887 →
Publication: US 2008/0124399
Orally Disintegrating Tablet Compositions of Lamotrigine
Patent: 7,919,115 →
Application: 12/166,757 →
Publication: US 2009/0092672
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Patent: 7,829,121 →
Application: 12/236,719 →
Publication: US 2009/0017126
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Patent: 7,790,199 →
Application: 12/236,723 →
Publication: US 2009/0017127
Orally Disintegrating Tablet Compositions of Lamotrigine
Patent: 8,647,656 →
Application: 12/628,677 →
Publication: US 2010/0303905
Modified Release Dosage Forms of Skeletal Muscle Relaxants
Application: 12/872,354 →
Publication: US 2011/0217384
Orally disintegrating tablet compositions of lamotrigine
Application: 60/929,536 →
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 14, 2003
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 014717/0397 →
Assignment of Assignor's Interest Dec 12, 2003
From: VENKATESH, GOPI; KRAMER, CRAIG
To: EURAND, INC.
Reel/Frame 014780/0505 →
Assignment of Assignor's Interest Feb 7, 2008
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 020473/0795 →
Assignment of Assignor's Interest Feb 7, 2008
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 020473/0810 →
Assignment of Assignor's Interest Jun 30, 2008
From: VENKATESH, GOPI; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 021171/0373 →
Assignment of Assignor's Interest Sep 24, 2008
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 021579/0134 →
Assignment of Assignor's Interest Sep 24, 2008
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 021579/0067 →
Assignment of Assignor's Interest Dec 22, 2008
From: VENKATESH, GOPI M.; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 022017/0537 →
Assignment of Assignor's Interest Feb 4, 2010
From: VENKATESH, GOPI M.; VYAS, NEHAL H.; GOSSELIN, MICHAEL; LAI, JIN-WANG
To: EURAND, INC.
Reel/Frame 023897/0180 →
Security Agreement Feb 11, 2011
From: EURAND, INCORPORATED
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025783/0548 →
Assignment of Assignor's Interest May 11, 2011
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 026262/0928 →
Corrective Assignment to Correct the Execution Date for Assignor Clevenger, James M. Should Be 11/13/2003 Previously Recorded on Reel 026262 Frame 0926. Assignor(S) Hereby Confirms the Executon Date for Assignor Clevenger, James M. Incorrectly Indicated as 11/13/2010. May 24, 2011
From: VENKATESH, GOPI M.; CLEVENGER, JAMES M.
To: EURAND, INC.
Reel/Frame 026340/0825 →
Release of Lien on Patents Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMATECH, INC.
Reel/Frame 031494/0925 →
Patent Security Agreement Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Change of Name Aug 5, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036283/0261 →
Change of Name Aug 18, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036380/0926 →
Change of Name Sep 25, 2015
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 036689/0358 →
U.S. Patent Security Agreement Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Security Interest Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276 Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Security Interest Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →